Enanta Pharmaceuticals (ENTA) FCF Margin Growth (5y) (2017 - 2026)
Enanta Pharmaceuticals (ENTA) FCF Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,831.00 |
| Dec 31, 2025 | -1,535.00 |
| Sep 30, 2025 | 9,688.00 |
| Jun 30, 2025 | 11,982.00 |
| Mar 31, 2025 | -20,420.00 |
| Dec 31, 2024 | -13,597.00 |
| Sep 30, 2024 | -12,070.00 |
| Jun 30, 2024 | -7,175.00 |
| Mar 31, 2024 | -25,412.00 |
| Dec 31, 2023 | -18,420.00 |
| Sep 30, 2023 | -11,616.00 |
| Jun 30, 2023 | -21,138.00 |
| Mar 31, 2023 | -6,757.00 |
| Dec 31, 2022 | -16,139.00 |
| Sep 30, 2022 | -16,006.00 |
| Jun 30, 2022 | -7,947.00 |
| Mar 31, 2022 | -10,165.00 |
| Dec 31, 2021 | -6,921.00 |
| Sep 30, 2021 | -10,132.00 |
| Jun 30, 2021 | -11,548.00 |